Pfizer, CStone Score China's Seventh Immuno-Oncology Approval

Cejemly To Enter Crowded Market

 
• By Brian Yang
Approvals
Seventh immuno-oncology therapy approved in China • Source: Alamy

More from China

More from Focus On Asia